SAMDaily.us | AWARD | Q | Tolerability studies of candidate AD drugs and efficacy of Poly(L-lysine succinylated)-hydroxychloroquine (PLS-HCQ) in a transgenic AD mouse model

SAMDAILY.US - ISSUE OF SEPTEMBER 14, 2022 SAM #7593
AWARD

Q -- Tolerability studies of candidate AD drugs and efficacy of Poly(L-lysine succinylated)-hydroxychloroquine (PLS-HCQ) in a transgenic AD mouse model

Notice Date: 9/12/2022 10:11:33 AM
Notice Type: Award Notice
NAICS: 541380 — Testing Laboratories
Contracting Office: NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
ZIP Code: 20892
Solicitation Number: 75N95022Q00316
Archive Date: 09/27/2022
Point of Contact: Rashiid Cummins
E-Mail Address: rashiid.cummins@nih.gov
(rashiid.cummins@nih.gov)
Award Number: 75N95022P00542
Award Date: 09/12/2022
Awardee: QPS Austria GmbH Steiermark 8074 AUT
Award Amount: 249000.00
Web Link: SAM.gov Permalink
(https://sam.gov/opp/2558ce121e0c4f8e8e989a0161dbd008/view)
Place of Performance: Address: AUT; Country: AUT
Record: SN06460609-F 20220914/220912230116 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |